Loading data
CRBPNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | 0 USD | 881.71 k USD |
| Research and development expense | 70.1 m USD | 32.22 m USD | 31.17 m USD | 16.14 m USD | 36.45 m USD |
| Operating profit | -85.31 m USD | -48.72 m USD | -45.08 m USD | -39.84 m USD | -55.99 m USD |
| Income tax expense | 0 USD | 0 USD | — | — | — |
| Net income (reported basis) | -78.54 m USD | -40.21 m USD | -44.6 m USD | -42.35 m USD | -45.64 m USD |
| Basic earnings per share | -5.9 USD/share | -3.68 USD/share | -10.31 USD/share | -10.15 USD/share | -11.15 USD/share |
| Diluted earnings per share | -5.9 USD/share | -3.68 USD/share | -10.31 USD/share | -10.15 USD/share | -11.15 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.